Financing channel feed

Backed by Or­biMed, Lil­ly and now Ad­van­tech, Chi­na's In­ven­tis­Bio loads up $70M to pro­pel can­cer, meta­bol­ic pipeline

7 years ago
China

Lund­beck fund backs a $50M launch round for SNIPR Bio­me, a new brand of CRISPR Cas biotech

7 years ago
Startups

At­ul Gawande takes aim at surg­ing pre­scrip­tion drug costs as chief of cryp­tic Buf­fett-Be­zos-Di­mon ven­ture now chris­tened 'Haven'

7 years ago
Pharma

French VC Sev­en­ture fo­cus­es sec­ond fund on fer­tile mi­cro­bio­me field — tar­gets €200M-plus

7 years ago

Gene edit­ing up­start backed by Broad star Feng Zhang nabs $135M, blue­print­ing a plat­form biotech for the long haul

7 years ago

Gene-edit­ing up­start lays out a $100M IPO with a plan to quick­ly leapfrog the lead­ers in their field

7 years ago

Look­ing to cap­i­tal­ize on ge­net­ic mod­i­fiers, Maze Ther­a­peu­tics launch­es with $191M in fi­nanc­ing led by Arch, Third Rock

7 years ago
Startups

Ahead of key NASH read­out, France's Gen­fit read­ies plans for $100M US IPO

7 years ago

Black­stone antes $250M on its first big biotech bet, fo­cused on a car­dio drug spun out of No­var­tis

7 years ago
Startups

Oys­ter Point in­vestors bet $93M on a PhI­II study aimed at dis­rupt­ing a ma­jor con­sumer mar­ket and top­pling Al­ler­gan

7 years ago

Temasek leads $85M round for Chi­nese biotech aim­ing for cheap­er, faster, bet­ter CAR-T ther­a­pies

7 years ago

MPM adds $408M for its next big wave of biotech star­tups — and on­col­o­gy still dom­i­nates the menu

7 years ago

Serono spin­off Ca­lyp­so Biotech be­comes res­i­dent at J&J's Eu­ro­pean in­cu­ba­tor, rais­es $22M+ in Se­ries A

7 years ago
Startups

Pelo­ton rais­es a mon­ster $150M in lat­est round, as lead drug heads for piv­otal tri­al

7 years ago

Backed by Or­biMed and J&J to build pre­ci­sion bac­te­ria-killing tool, Bio­mX adds a slate of in­vestors in $32M Se­ries B

7 years ago
Startups

Morn­ing­side spawned Stealth Bio’s IPO stum­bles out of the gate, rais­ing $78M

7 years ago

James Wil­son turns to old men­tor for gene ther­a­py star­tup's star-stud­ded $115M launch round

7 years ago
Startups

In HKEX's first test in 2019, CStone seeks up to $304M in IPO for­tune

7 years ago
China

Busy VC 5AM eclipses $125M tar­get for fund to in­ject cap­i­tal in­to ex­ist­ing port­fo­lio, meets goal for sixth biotech fund

7 years ago

Hill­house Cap­i­tal en­dors­es Chi­na-based Hai­He Bio­phar­ma's can­cer pipeline in $146M round

7 years ago
China

Af­ter a short stint at In­ter­cept, Rachel McMinn makes the leap from biotech an­a­lyst to biotech CEO

7 years ago
People
Startups

Canaan leaps in­to UK biotech by co-lead­ing $14M Se­ries A for im­muno-on­col­o­gy up­start Grey Wolf

7 years ago
Startups

2019's sec­ond uni­corn Gos­samer rais­es $276M in up­sized IPO of­fer­ing, MP­M's Har­poon makes its Nas­daq de­but with $75.6M boun­ty

7 years ago

The biotech uni­corns are back: Alec­tor bur­nish­es its $1.3B val­u­a­tion in an IPO that gen­er­ates $176M in cash

7 years ago
First page Previous page 115116117118119120121 Next page Last page
A service from the Financial Times